Cart
sales@molnova.com
ARRY-797
CAS No. 1036404-17-7
ARRY-797( ARRY-371797 | ARRY-797 )
Catalog No. M28777 CAS No. 1036404-17-7
ARRY-797 is a potent and selective p38α inhibitor and inhibits LPS-Induced IL-6.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 131 | Get Quote |
|
| 10MG | 218 | Get Quote |
|
| 25MG | 385 | Get Quote |
|
| 50MG | 655 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameARRY-797
-
NoteResearch use only, not for human use.
-
Brief DescriptionARRY-797 is a potent and selective p38α inhibitor and inhibits LPS-Induced IL-6.
-
DescriptionARRY-797 is a potent and selective p38α inhibitor and inhibits LPS-Induced IL-6.(In Vivo):ARRY-797 inhibits the growth of RPMI-8226 Human Multiple Myeloma Cells. ARRY-371797 prevented left ventricular dilatation and deterioration of fractional shortening compared with placebo-treated mice.
-
In Vitro——
-
In Vivo——
-
SynonymsARRY-371797 | ARRY-797
-
PathwayApoptosis
-
TargetIL Receptor
-
RecptorMicrotubule/Tubulin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1036404-17-7
-
Formula Weight——
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An W, et al. Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents. Eur J Med Chem. 2016 Apr 13;112:367-372.
molnova catalog
related products
-
2-Benzothiazolamine
2-Aminobenzothiazole is an organic compound.
-
Ixekizumab
Ixekizumab (LY2439821) is a humanized IgG4 monoclonal antibody that selectively binds and neutralizes interleukin IL-17A with a Kd value of <3 pM. It blocks the binding of IL-17A to IL-17RA but not to other IL-17 family members.
-
Risankizumab
Risankizumab (BI 655066) is a humanized IgG monoclonal antibody (Kd <10 pM) targeting the IL-23 p19 subunit. It inhibits IL-17 production induced by human IL-23 in mouse splenocytes with an IC50 value of 2 pM.
